Skip to content

Sensititre FRAM1ANA

by Trek Diagnostic Systems Ltd

Ref FRAM1ANA

Sensititre FRAM1ANA is an in vitro diagnostic device (EU IVDD general IVD; EMDN category manual susceptibility testing) made by Trek Diagnostic Systems Ltd, registered in EUDAMED on 26 Oct 2026 (Basic UDI-DI B-05032384547982), active as of 7 Nov 2026.

Active European Union

CE IVDD

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None, self-declared

Class I: no certifier involved

Trust

Unverified

Source EUDAMED, synced 7 Nov 2026.

Regulatory status

as of registry sync 7 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-05032384547982 Basic UDI-DI 05032384547982UDI-DIDate26 Oct 2026RegisteredStatusActive

Official records

Certificates

0 certificates · EUDAMED

No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/IVDD Active

Specification

EUDAMED

Model / reference
FRAM1ANA
Primary DI / UDI-DI
05032384547982
Basic UDI-DI
B-05032384547982
EMDN code
W0104080599 Manual susceptibility testing - other
Device class
Class IVD General
EU registration type
Legacy device (under a directive)
EU market of registration
Netherlands

Manufacturer details

EUDAMED SRN
GB-MF-000016922
Authorised representative
Thermo Fisher Diagnostics B.V. NL-AR-000013157

Similar devices in this category

Other devices filed under MANUAL SUSCEPTIBILITY TESTING.

Other devices from Trek Diagnostic Systems Ltd

See all devices from Trek Diagnostic Systems Ltd →

Properties

  • Contains animal tissues or cells
  • Reagent
  • Professional testing
Other properties (9, all answered No)